Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2010
10/27/2010CN101869633A Enteric-coated medicament combination containing epigallocatechin gallate
10/27/2010CN101869629A Traditional Chinese medicine for treating renal calculus
10/27/2010CN101869598A Compound evening primrose and perilla herb oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869592A Formula and preparation method of pollen product
10/27/2010CN101869580A Oral administration solid preparation for treating renal failure
10/27/2010CN101869554A Doxazosin mesylate controlled release tablet and preparation technology thereof
10/27/2010CN101361786B Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/27/2010CN101279007B Chinese medicine for curing aconuresis
10/27/2010CN101249261B Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
10/27/2010CN101002589B Health-care medicine tea for sobering and taking care of liver and kidney
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2304700C Lipophilic diesters of chelating agents
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119347A1 Netupitant for use in treating bladder dysfunction
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010059967A3 Amide inhibitors of renin
10/21/2010US20100267829 Pharmaceutical composition comprising low concentrations of environment pollutants
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267764 8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/21/2010US20100267741 Compounds, Compositions and Methods Comprising Pyrazole Derivatives
10/21/2010US20100267736 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267735 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267706 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267626 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100266712 Prevention of Acute Kidney Injury
10/21/2010US20100266707 Method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266644 Methods and compositions for administration of iron
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266501 Methods and compositions for organ protection
10/21/2010DE202010008308U1 Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Harnwegsinfekten und/oder bakteriellen Entzündungen der Schleimhäute Composition for nutritional supplement or treatment of urinary tract infections and / or bacterial inflammation of the mucous membranes
10/20/2010EP2241887A2 Diagnostics, drug screening and treatment for cancer
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2240180A2 Prevention of recurrence of urethral stricture after a conventional treatment
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
10/20/2010CN1994155B Healthy oral liquid and preparation method thereof
10/20/2010CN101868535A Kidney-derived stem cell population, identification and therapeutic use
10/20/2010CN101864400A Specific recombinant adenoviruses, preparation thereof and use thereof
10/20/2010CN101863984A Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane
10/20/2010CN101863960A Preparation method of cetrorelix
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863870A Tectorigenin derivatives, and preparation method and application thereof in treating prostatic diseases
10/20/2010CN101862449A Compositions and methods for treatment of candidiasis
10/20/2010CN101862428A Chinese medicament for treating benign prostatic hyperplasia
10/20/2010CN101862407A Chinese compound heat clearing and blood circulation promoting suppository
10/20/2010CN101862390A Chinese composition for treating urinary tract infection
10/20/2010CN101862379A Chinese medicament for treating kidney failure
10/20/2010CN101862374A Lotus plumule and new application of extractive thereof
10/20/2010CN101862370A Separation method of broussonetia active ingredients
10/20/2010CN101862358A Acute turpinia leaf ethanol percolation extract, and preparation method and application thereof
10/20/2010CN101862357A Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101485736B Medicament composition with stone-eliminating and expelling functions and preparation method thereof
10/20/2010CN101367862B Method for quickly and massively separating high purity triptolide from thunder god vine
10/20/2010CN101167707B New use of protocatechuic aldehyde
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2439791C Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118291A2 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
10/14/2010WO2010115291A1 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
10/14/2010US20100261787 Pharmaceutical composition for diabetic nephropathy and its preparation and application
10/14/2010US20100261782 Intra-vascular kidney gene therapy with plasmid encoding bmp-7
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261770 Pharmaceutical composition for improving lower urinary tract symptoms
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261734 Methods of Treating Bladder Dysfunction Using Netupitant
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 562